2014—2022年中药新药审评与医保准入时长分析
A study on evaluation duration and insurance admission of new traditional Chinese medicine drug approvals from 2014—2022
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |